title: Enterobacter cloacae infection of an expanded polytetrafluoroethylene femoral-popliteal bypass graft: a case report.
abstract: BACKGROUND
  Enterobacter cloacae infections are common among burn victims, immunocompromised patients, and patients with malignancy. Most commonly these infections are manifested as nosocomial urinary tract or pulmonary infections. Nosocomial outbreaks have also been associated with colonization of certain surgical equipment and operative cleaning solutions. Infections of an aortobifemoral prosthesis, an aortic graft, and arteriovenous fistulae are noted in the literature. To our knowledge, this is the first isolated account of an E. cloacae infection of a femoral-popliteal expanded polytetrafluoroethylene bypass graft.
  
  
  METHODS
  A 68-year-old Caucasian man presented with fever and rest pain in the right lower extremity five months after the placement of a vascular expanded polytetrafluoroethylene graft for femoral-popliteal bypass. Computed tomography angiography demonstrated peri-graft fluid that was aspirated percutaneously with image guidance and cultured to reveal E. cloacae. The graft was revised and then removed. The patient completed a six-week course of ceftazidime and is currently without signs of infection. There were no other reports of E. cloacae graft infections in any patients receiving treatment in the same surgical suite within a month of this report.
  
  
  CONCLUSIONS
  Isolated cases of E. cloacae infection of surgical bypass grafts are rare (unique in this setting). Clinicians should have a high index of suspicion for device contamination in such cases and should consider testing for possible microbial reservoirs. Graft removal is required due to the formation of biofilm and the recent emergence of Enterobacteriaceae producing extended-spectrum beta-lactamase in community acquired infections.
authors.affiliation: Tucson Hospitals Medical Education Program, 1501 N, Campbell Avenue, PO Box 245066, Tucson, Arizona 85724-5066, USA. Sue.Corcoran@tmcaz.com.
authors.forename: Ian
authors.initials: I
authors.lastname: Musil
authors.forename: Vanessa
authors.initials: V
authors.lastname: Jensen
authors.forename: Jolyon
authors.initials: J
authors.lastname: Schilling
authors.forename: Boyd
authors.initials: B
authors.lastname: Ashdown
authors.forename: Tyler
authors.initials: T
authors.lastname: Kent
references.citation: Scand J Infect Dis. 1989;21(2):181-91
references.pmid: 2727635
references.citation: An Med Interna. 2002 May;19(5):246-50
references.pmid: 12108001
references.citation: J Antimicrob Chemother. 2005 Dec;56(6):996-9
references.pmid: 16269550
references.citation: N Engl J Med. 1989 Oct 5;321(14):935-40
references.pmid: 2779615
references.citation: Nefrologia. 2003 Jul-Aug;23(4):333-43
references.pmid: 14558333
references.citation: Am J Infect Control. 1994 Aug;22(4):195-201
references.pmid: 7985817
references.citation: Mol Biosyst. 2005 Sep;1(3):196-202
references.pmid: 16880983
references.citation: J Am Soc Nephrol. 1998 Jul;9(7):1314-7
references.pmid: 9644644
references.citation: J Infect. 2006 Jul;53(1):49-55
references.pmid: 16310254
references.citation: Surg Gynecol Obstet. 1988 Apr;166(4):295-301
references.pmid: 3127896
references.citation: J Thorac Cardiovasc Surg. 1986 Feb;91(2):296-302
references.pmid: 3753734
references.citation: J Antimicrob Chemother. 2005 Jul;56(1):52-9
references.pmid: 15917288
references.citation: Am J Surg. 1973 Dec;126(6):798-802
references.pmid: 4758802
references.citation: J Vasc Interv Radiol. 2009 Feb;20(2):173-9
references.pmid: 19097807
references.citation: Ann Vasc Surg. 1992 Nov;6(6):517-24
references.pmid: 1463665
references.citation: Surg Gynecol Obstet. 1974 Sep;139(3):446-52
references.pmid: 4277536
references.citation: Chest. 1978 Nov;74(5):508-13
references.pmid: 738087
references.citation: J Vasc Surg. 2001 May;33(5):948-54
references.pmid: 11331833